Patents by Inventor Gerald R. Girard

Gerald R. Girard has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Novel mmp-2/mmp-9 inhibitors
    Publication number: 20030225272
    Abstract: Novel MMP-2/MMP-9 inhibitors and methods of using them are provided.
    Type: Application
    Filed: April 4, 2003
    Publication date: December 4, 2003
    Inventors: Anne Romanic Arnold, Balan Chenera, Gerald R. Girard, Joseph Weinstock
  • Phosphate transport inhibitors
    Publication number: 20030212074
    Abstract: Dihydroxybenzamides, useful for treatment of chronic renal failure and uremic bone disease, are disclosed.
    Type: Application
    Filed: October 29, 2002
    Publication date: November 13, 2003
    Inventors: Dimitri Gaitanopoulos, Gerald R. Girard, Joseph Weinstock
  • Method of antagonizing angiotensin II receptors in mammals using substituted [1H-Imidazol-5-YL] alkenoic acids
    Patent number: 5530017
    Abstract: Angiotensin II receptor antagonists having the formula: ##STR1## which are useful in regulating hypertension and in the treatment of congestive heart failure, renal failure, and glaucoma, pharmaceutical compositions including these antagonists, and methods of using these compounds to produce angiotensin II receptor antagonism in mammals.
    Type: Grant
    Filed: May 2, 1995
    Date of Patent: June 25, 1996
    Assignee: SmithKline Beecham Corp
    Inventors: Gerald R. Girard, Judith Hempel, David T. Hill, James Samanen, Joseph Weinstock
  • N-(heteroaryl) imidazolyl-alkenoic acids having angiotension II receptor antagonist activity
    Patent number: 5447949
    Abstract: Angiotensin II receptor antagonists having the formula: ##STR1## which are useful in regulating hypertension and in the treatment of congestive heart failure, renal failure, and glaucoma, pharmaceutical compositions including these antagonists, and methods of using these compounds to produce angiotensin II receptor antagonism in mammals.
    Type: Grant
    Filed: November 15, 1993
    Date of Patent: September 5, 1995
    Assignee: SmithKline Beecham Corporation
    Inventors: Gerald R. Girard, David T. Hill, Joseph Weinstock
  • Substituted [1H-imidazol-5-ylialkanoic acids having angiotension II receptor antagonist activity
    Patent number: 5444080
    Abstract: Angiotensin II receptor antagonists having the formula: ##STR1## which are useful in regulating hypertension and in the treatment of congestive heart failure, renal failure, and glaucoma, pharmaceutical compositions including these antagonists, and methods of using these compounds to produce angiotensin II receptor antagonism in mammals.
    Type: Grant
    Filed: January 29, 1993
    Date of Patent: August 22, 1995
    Assignee: SmithKline Beecham Corporation
    Inventors: Gerald R. Girard, Judith Hampel, David T. Hill, James Samanen, Joseph Weinstock
  • Substituted N-(imidazolyl)alkyl alanine derivatives
    Patent number: 5248689
    Abstract: Angiotensin II receptor antagonists having the formula: ##STR1## which are useful in regulating hypertension and in the treatment of congestive heart failure, renal failure, and glaucoma, pharmaceutical compositions including these antagonists, and methods of using these compounds to produce angiotensin II receptor antagonism in mammals.
    Type: Grant
    Filed: September 28, 1990
    Date of Patent: September 28, 1993
    Assignee: SmithKline Beecham Corporation
    Inventors: Gerald R. Girard, David T. Hill, Joseph Weinstock
  • Tandem photovoltaic solar cell with III-V diffused junction booster cell
    Patent number: 5123968
    Abstract: A photovoltaic cell array involving rows and columns of tandem or stacked solar cell units composed of GaSa/GaSb associated with a radiation collector have produced measured energy conversion efficiencies of 31% AMO. The booster GaSb cell is manufactured by a process which produces a p-type diffusion region within an n-type substrate, has improved energy conversion efficiencies and can be mounted as part of a four terminal stacked solar cell unit.
    Type: Grant
    Filed: June 19, 1991
    Date of Patent: June 23, 1992
    Assignee: The Boeing Company
    Inventors: Lewis M. Fraas, James E. Avery, Gerald R. Girard
  • Tandem photovoltaic solar cell with III-V diffused junction booster cell
    Patent number: 5091018
    Abstract: A photovoltaic cell array involving rows and columns of tandem or stacked solar cell units composed of GaSa/GaSb associated with a radiation collector have produced measured energy conversion efficiencies of 31% AMO. The booster GaSb cell is manufactured by a process which produces a p-type diffusion region within an n-type substrate, has improved energy conversion efficiencies and can be mounted as part of a four terminal stacked solar cell unit.
    Type: Grant
    Filed: May 14, 1990
    Date of Patent: February 25, 1992
    Assignee: The Boeing Company
    Inventors: Lewis M. Fraas, James E. Avery, Gerald R. Girard
  • Inhibiting phenylethanolamine N-methyltransferase with thiadiazolo and oxadiazolotetrahydroisoquinolines
    Patent number: 4258049
    Abstract: Thiadiazolo- and oxadiazolotetrahydroisoquinoline compounds are inhibitors of phenylethanolamine N-methyltransferase.
    Type: Grant
    Filed: March 17, 1980
    Date of Patent: March 24, 1981
    Assignee: SmithKline Corporation
    Inventors: William E. Bondinell, Gerald R. Girard